Pharmacokinetic patterns of risperidone-associated adverse drug reactions.

Georgios SchoretsanitisBenedikt StegmannChristoph HiemkeGerhard GründerKoen R J SchruersSebastian WaltherSarah E LammertzEkkehard HaenMichael Paulzen

Published in: European journal of clinical pharmacology (2016)

Our findings are consistent with previous data supporting a prominent role of 9-hydroxyrisperidone, but not of risperidone with regard to ADRs. When studying the various subgroups of reported ADRs separately, the size of these subsamples offers some plausible limitations by reducing the power of the analysis.

Keyphrases

adverse drug
electronic health record
emergency department
big data
machine learning
artificial intelligence